HIV/AIDS

COVID-19 lockdown may have accelerated HIV transmission in some at-risk populations

A new study led by researchers at UBC and the BC Centre for Excellence in HIV/AIDS (BC-CfE) is shedding light on how COVID-19 pandemic restrictions impacted another long-standing public health threat — HIV.

Sep 23, 2022

Screening in pregnancy key to eliminating mother-to-child HIV transmission

Canada has almost eliminated mother-to-child HIV transmission, known as vertical transmission, in recent years.

Jul 22, 2015

HIV treatment has social and socioeconomic benefits, as well as improved health: study

New research shows that HIV treatment for illicit drug users improves their social and socioeconomic wellbeing as well as their health.

Jul 21, 2015

One stop health care model transforms HIV treatment in South Africa

Providing HIV care at local health clinics in South Africa has led to a massive increase in the number of people there receiving vital HIV treatment, according to UBC research.

Jul 21, 2015

What is HIV Treatment as Prevention?

As the 2015 International Aids Society Conference gets underway in Vancouver, B.C., researcher M-J Milloy outlines how Treatment as Prevention, a made-in-B.C. approach, has the potential to end the spread of HIV/AIDS.

Jul 20, 2015

World’s top HIV/AIDS researchers converge on Vancouver

UBC and the BC Centre for Excellence in HIV/AIDS (BC-CfE) will welcome more than 6,000 of the world’s leading HIV/AIDS experts to Vancouver next week.

Jul 16, 2015

HIV/AIDS Treatment as Prevention strategy working in B.C. Montaner calls for national implementation

A new study from the BC Centre for Excellence in HIV/AIDS (BC-CfE) shows highly active antiretroviral therapy (HAART) reduces new HIV diagnoses, deaths and HIV prevalence, suggesting that the made-in-Canada Treatment as Prevention strategy should be implemented across the country.

Nov 27, 2012

Adherence to HIV treatment significantly increases survival: UBC study

HIV-positive individuals who strictly adhere to highly active antiretroviral therapy (HAART) have a significantly lower probability of premature morbidity and mortality as compared to those with suboptimal compliance to HAART, according to a new study from the BC Centre for Excellence in HIV/AIDS (BC-CfE).

Nov 20, 2012

Funding for neglected global diseases research at UBC exceeds $20M

Researchers with the Neglected Global Diseases Initiative (NGDI) at the University of British Columbia have attracted more than $20 million in funding to find ways to eliminate diseases and conditions that kill millions of people in developing countries worldwide.

Sep 10, 2012

UBC drug formulation receives $1.1 million for clinical development as HIV treatment

A drug delivery system developed through the University of British Columbia’s Neglected Global Diseases Initiative and licensed to iCo Therapeutics Inc. will receive $1.1 million from the National Research Council of Canada (NRC) for clinical development as a treatment for HIV patients.

Jun 5, 2012

UBC researcher wins 2012 Trudeau Foundation scholarship

Daniel Werb, senior research assistant at the Addiction and Urban Health Research Initiative (UHRI) at the BC Centre for Excellence in HIV/AIDS (BC-CfE), has been awarded the 2012 Pierre Elliott Trudeau Foundation Doctoral Scholarship for his PhD research project investigating initiation and cessation of injection drug use among street youth in Vancouver.

May 15, 2012

Allegations against UBC researchers’ study on Insite “without merit:” independent reviewer

An independent reviewer has dismissed concerns over a study that shows a 35-per-cent decrease in overdose deaths after the opening of Insite, North America’s only supervised injection facility.

Oct 18, 2011